4BIO CAPITAL is a trade name of 4BIO Ventures Management Ltd, which is authorised and regulated by the Financial Conduct Authority, register number 775193
© 2015-2019 by 4BIO Ventures Management Ltd

GENE THERAPY

  • Gene therapies allow treatment of previously unapproachable genetic and metabolic diseases with significant unmet medical needs
     

  • Gene editing, while earlier in development than current gene therapies, potentially allows treatment of a wider disease range

THERAPEUTIC AREAS

  • All monogenic disorders

  • Gain-of-function disorders 

  • Oncology

  • Autoimmune disorders